[Clinicopathological observation on 2 cases of nasal-type NK/T-cell lymphoma in the esophagus].
Zhang
Shu
S
Wang
Hai
H
Leng
Dong-ni
DN
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019002:CD56 Antigen / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000532:radiotherapy; D005500:Follow-Up Studies; D006801:Humans; D017493:Leukocyte Common Antigens / Q000378:metabolism; D054391:Lymphoma, Extranodal NK-T-Cell / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D039102:Poly(A)-Binding Proteins / Q000378:metabolism; D011241:Prednisone / Q000627:therapeutic use; D000074019:T-Cell Intracellular Antigen-1; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
D019002:CD56 Antigen; D039102:Poly(A)-Binding Proteins; D000074019:T-Cell Intracellular Antigen-1; C071558:TIA1 protein, human; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D017493:Leukocyte Common Antigens; D011241:Prednisone